Company intelligence / Profile preview

Dirinco

Ossnoord, North Brabant, Netherlands

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Dirinco is a medical device company based in the Netherlands and Switzerland specializing in hemodialysis and critical care solutions. Founded in 1986, the company has evolved into an expert in extracorporeal circulation treatment of renal failure and catheter lock solutions. Its product, Citra-Lock, has demonstrated superior efficacy compared to taurolidine-based locking solutions in preventing thrombotic dysfunction of tunneled hemodialysis catheters.

Therapeutic areas: Nephrology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Dirinco.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dirinco.

Explore the full profile